Skip to main content

Weather alert

Due to winter storm Fern, our Patient Service Centers in affected areas may be closed. We ask that patients please double check your appointment status to ensure your designated Patient Service Center is operational. For site-specific information, please use Find a location and enter your zip code.

Hide
Quest Diagnostics

Shorter Drug Testing Intervals Are Associated With Improved Drug Misuse Rates

Shorter Drug Testing Intervals Are Associated With Improved Drug Misuse Rates

Authors: Gudin J, Mehta N, McClure FL, Niles JK, Kaufman HW

Citation: J Opioid Manag. 2020;16:357-373. doi:10.5055/jom.2020.0591

Specialties: Toxicology, Pain management, Prescription Drug Monitoring

Download key summary

Related content

Audio Podcast
Contributing Factors to the Skyrocketing Drug Misuse Epidemic in the US
Audio Podcast
Presumptive vs Definitive Drug Testing: What You Need to Know
Test FAQ
Drug Toxicology Monitoring Oral Fluid Testing
Audio Podcast
Phosphatidylethanol (PEth) blood test - Now available from Quest Diagnostics
Audio Podcast
Limitations of point-of-care drug testing

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.